EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer

Date

2019-09-01

Author

Asik, Elif
Akpinar, Yeliz
Caner, Ayse
Kahraman, Nermin
Güray, Nülüfer Tülün
Volkan, Mürvet
Albarracins, Constance
Pataer, Apar
Arun, Banu
Ozpolat, Bulent

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

205
views

0
downloads

Aim: To investigate the role of EF2K in BRCA1-mutated breast cancer. Materials & methods: We developed silica coated cobalt-ferrite (CoFe) nanoparticles for in vivo delivery of small interfering RNAs (siRNAs) into BRCA1-mutated breast cancer. Results: Expression of EF2K is highly upregulated in themajority (78.5%) of BRCA1-mutated patients and significantly associated with poor patient survival and metastasis. Silencing of EF2K reduced cell proliferation, migration and invasion of the cancer cells. In vivo therapeutic targeting of EF2K by CoFe-siRNA-nanoparticles leads to sustained EF2K gene knockdown and suppressed tumor growth in orthotopic xenograft models of BRCA1-mutated breast cancer. Conclusion: EF2K is a potential novel molecular target in BRCA1-mutated tumors and CoFe-based siRNA nanotherapy may be used as a novel approach to target EF2K.

Subject Keywords

Development, General Materials Science, Medicine (miscellaneous), Bioengineering, Biomedical Engineering

URI

https://hdl.handle.net/11511/37857

Journal

NANOMEDICINE

DOI

https://doi.org/10.2217/nnm-2019-0132

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Amitriptyline; a systems biomedicine-oriented repositioned drug candidate for breast cancer Taş, Fadime Dilşad; Okutan, Keziban; Ceylan, Tuğba; Özkaya, Ömer Faruk; Aydın, Büşra (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Introduction: Breast cancer (BRCA) is a disease where the growth of breast cells is out of control. According to WHO’s latest cancer statistics, the BRCA is the world’s most prevalent cancer. In clinic, there are possible treatments that target cancer cells such as chemotherapy, radiation, or hormone therapies. However, these treatments have long-term side effects that can occur even multiple years after the treatment which may lead to even notorious consequences. Methods: Transcriptome-level BRCA gene expr...
Camptothecin Anticancer Drug Loaded Iron Oxide Micro and Nanoparticles: Tuning Targeted and Sustained Release of the Drug in Bioactive Form Gokduman, Kurtulus; Demir, Ayhan Sıtkı (Bentham Science Publishers Ltd., 2013-12-01) Although Camptothecin (CPT) has significant antitumor activity to lung, ovarian, breast, pancreas, and stomach cancers; lactone ring opening causes a reduction in cytotoxic activity and severe side effects in physiological conditions (pH: 7.4, 37 degrees C) due to decreased cell membrane binding, membrane diffusibility, and intrinsic potency against the topoisomerase target. Taken into consideration the targeted delivery advantage of biocompatible magnetic particles, in order to contribute to the removal of...
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer Assidicky, Ridho; Tokat, Unal Metin; Tarman, Ibrahim Oguzhan; Saatci, Ozge; Ersan, Pelin Gulizar; Raza, Umar; Ogul, Hasan; Riazalhosseini, Yasser; Can, Tolga; Sahin, Ozgur (2022-03-01) Purpose Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that is frequently treated with chemotherapy. However, many patients exhibit either de novo chemoresistance or ultimately develop resistance to chemotherapy, leading to significantly high mortality rates. Therefore, increasing the efficacy of chemotherapy has potential to improve patient outcomes. Methods Here, we performed whole transcriptome sequencing (both RNA and small RNA-sequencing), coupled with network simu...
Multidrug resistance in logally advanced breast cancer Atalay, Mustafa Can; Gündüz, Ufuk; Department of Biotechnology (2004) Breast cancer is the most frequently detected cancer among women. Early diagnosis leads to long term survival when the patients are treated with surgery, radiotherapy, chemotherapy, and hormone therapy. Unfortunately, advanced disease could still be encountered in some patients resulting in a poorer prognosis. The primary treatment modality is chemotherapy for this group of patients. Drug resistance is a serious problem resulting in the use of different drugs during chemotherapy and knowing the possibility ...
N-Propargylic β-enaminones in breast cancer cells: Cytotoxicity, apoptosis, and cell cycle analyses Ilhan, Suleyman; Atmaca, Harika; Yılmaz, Elif Serel; YILDIZ, ESRA; Zora, Metin (2023-01-01) Breast cancer is one of the most common cancers worldwide and the discovery of new cytotoxic agents is needed. Enaminones are regarded to be a significant structural motif that is found in a variety of pharmacologically active compounds however the number of studies investigating the anticancer activities of N-propargylic β-enaminones (NPEs) is limited. Herein we investigated the potential cytotoxic and apoptotic effects of 23 different NPEs (1-23) on human breast cancer cells. Cytotoxicity was evaluated vi...

Citation Formats

E. Asik et al., “EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer,” NANOMEDICINE, pp. 2315–2338, 2019, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/37857.